Biogen Inc. (BIIB) Q3 FY25 Earnings Call

Launch products generated $257 million, up 67%, while full-year sales guidance is flat to up 1%.

Q3 FY25 results, source: company transcript and SEC filings
QuarterQ3 FY25
Call date2025-10-30
Length69 minutes
EPS$4.81
EPS consensus$3.89
Revenue$2.5B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q1 FY26 · Q4 FY25 · Q2 FY25 · Q1 FY25 · Q4 FY24

Read the full Q3 FY25 earnings call transcript

All BIIB earnings · Back to BIIB overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.